Core Insights - Canadian sustainability reporting is facing significant challenges but also presents major opportunities, with an increasing demand for high-quality sustainability-related and climate-related information [3][4] Group 1: Event Overview - The Canadian Sustainability Standards Board (CSSB) and the UN-supported Principles for Responsible Investment (PRI) are hosting a live panel discussion titled "Sustainability Disclosure in Canada: Overcoming the Headwinds" during Canada Climate Week Xchange [2][3] - The event will feature remarks from Elizabeth Dove, Executive Director of UN Global Compact Network Canada, followed by a panel discussion with regulators and sustainability disclosure leaders [3][4] Group 2: Panel Discussion Focus - Panelists will discuss the value, challenges, and future of sustainability reporting in Canada, exploring how the country can enhance its resilience and competitiveness on the global stage [4] - Attendees will have the opportunity to gain insights from key decision-makers and engage in discussions with peers navigating the evolving landscape of sustainability reporting [4] Group 3: CSSB's Role - The CSSB is responsible for developing sustainability disclosure standards for Canada, building on the global baseline set by the International Sustainability Standards Board (ISSB) [8] - The CSSB aims to promote high-quality, comparable sustainability reporting that enhances transparency, accountability, and confidence in Canadian markets [8]

New York, New York--(Newsfile Corp. - November 18, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2026.SO WHAT: If you purchased Stride a securities during the Class Pe ...

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for securities fraud, alleging significant stock drops due to potential violations of federal securities laws [1][3]. Company Overview - Stride, Inc. is an education technology company that provides an online platform to students across the U.S. [4]. Allegations - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students," ignored compliance requirements, and had a poor customer experience leading to higher withdrawal rates and lower conversion rates [4]. - Stride's statements about "increasing growth" and "strength in demand" are alleged to be misleading [4]. Stock Performance - On September 14, 2025, a report of the lawsuit caused Stride's stock to drop by $18.60, or over 11%, from $158.36 to $139.76 per share [5]. - Following Stride's admission of poor customer experience on October 28, 2025, the stock plummeted by $83.48, or more than 54%, from $153.53 to $70.05 per share [6]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia [3]. - The lawsuit is captioned MacMahon v. Stride, Inc., et al., No. 1:25-cv-02019 [3]. Investor Actions - Investors are encouraged to seek additional information and may have legal options available [2][7].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [4]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting evaluations of historical collection trends [5]. - The company increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [5]. - Following the financial disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [5]. Legal Context - The investigation is being led by Bleichmar Fonti & Auld LLP, a law firm specializing in securities class actions [2][7]. - Investors are encouraged to seek legal options and submit their information to the firm, which operates on a contingency fee basis [6].

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for securities fraud following a significant stock drop due to alleged violations of federal securities laws [2][4]. Company Overview - Inspire Medical Systems, Inc. develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [5]. Allegations and Issues - The lawsuit claims that Inspire misled investors by assuring them that all necessary steps were taken for the launch of Inspire V, while in reality, the company failed to prepare clinicians and payors adequately, leading to delays in adoption [6][7]. - The company faced weak demand for Inspire V as many customers had excess inventory of older devices [7]. Stock Performance - On August 4, 2025, Inspire disclosed that the launch of Inspire V would take longer than expected, resulting in a reduction of its 2025 earnings per share guidance by over 80% [8]. - Following this announcement, Inspire's stock price dropped by $42.04 per share, or more than 32%, from $129.95 to $87.91 between August 4 and August 5, 2025 [9].

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc for securities fraud, following a significant stock drop attributed to potential violations of federal securities laws [2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, with a deadline for investors to seek lead plaintiff status by December 23, 2025 [4]. - The complaint alleges violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in James Hardie common stock [4]. Group 2: Company Background - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [5]. Group 3: Allegations of Fraud - During the relevant period, James Hardie claimed strong performance in its North American fiber cement segment, asserting "inherent strength" and "underlying momentum" in its strategy [6]. - However, it is alleged that the reported sales were due to inventory loading by channel partners rather than genuine customer demand, indicating potential fraudulent practices [6]. Group 4: Stock Performance - On August 19, 2025, James Hardie disclosed a 12% decline in North American fiber cement sales, attributed to destocking efforts by customers [7]. - Following this announcement, the stock price plummeted by $9.79 per share, a decrease of over 34%, from $28.43 to $18.64 [7].

MLTX CLASS NOTICE: BFA Law Alerts MoonLake Immunotherapeutics Investors of the Pending Securities Fraud Class Action and Upcoming December 15 DeadlineNovember 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the fe ...

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of California, titled Kim v. Synopsys, Inc., et al., No. 3:25-cv-09410 [3]. - Investors have until December 30, 2025, to request to be appointed to lead the case [3]. Group 2: Company Performance and Allegations - Synopsys provides design automation software and has seen its Design IP segment grow from 25% of revenue in 2022 to 31% in 2024 [4]. - The company previously claimed that customers relied on its IP to minimize integration risk and noted strength in Europe and South Korea [5]. - Allegations state that customers began requiring more customization for IP components, negatively impacting the economics of the Design IP business [5]. Group 3: Financial Impact - On September 9, 2025, Synopsys reported Q3 2025 results, revealing a 7.7% year-over-year decline in Design IP revenue to $425.9 million and a 43% year-over-year decline in net income to $242.5 million [6]. - Following the release of these results, Synopsys stock fell nearly 36%, from $604.37 per share to $387.78 per share [6].

KMX CLASS NOTICE: BFA Law Alerts CarMax, Inc. Investors of the Pending Securities Fraud Class Action and Upcoming January 2 DeadlineNovember 18, 2025 3:33 PM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resul ...

Core Viewpoint - Beyond Meat, Inc. is under investigation for potential violations of federal securities laws related to the inflation of certain long-lived assets' values [1][4]. Group 1: Company Overview - Beyond Meat specializes in plant-based meat alternatives [3]. - The company underwent a global operations review in late 2023, leading to the depreciation of certain long-lived assets [3]. Group 2: Stock Performance - On October 24, 2025, Beyond Meat announced an expected non-cash impairment charge for the three months ended September 27, 2025, which was anticipated to be material. This announcement caused the stock price to drop approximately 23%, from $2.84 per share on October 23, 2025, to $2.185 per share on October 24, 2025 [5]. - Following the announcement of a delay in the earnings report for Q3 2025 on November 3, 2025, the stock experienced a significant decline during trading on that day [6].